康基醫療(09997.HK)年度純利增長82.5%至4.57億元 末期息17.23港仙
格隆匯3月22日丨康基醫療(09997.HK)發佈公吿,截至2021年12月31日年度,公司收入6.90億元人民幣,同比增長35.0%;毛利5.63億元,同比增長30.5%;公司擁有人應占淨利潤4.57億元,同比增長82.5%;每股盈利37.31分,末期股息每股17.23港仙。
截至2021年12月31日止年度,公司總收入較2020年增長35.0%。公司的銷售額增長乃由於中國擇期手術量的顯著回升、公司經銷商網絡的擴展及優化、新產品的銷售貢獻及出口銷售增長。
集團於報吿期內母公司擁有人應占純利同比增加82.5%。增加的主要原因是收入增加、其他收入(如銀行利息收入)增加、股權投資公允價值收益、未產生上市開支及非控股權益以及以股份為基礎的付款開支減少。集團非《香港財務報吿準則》經調整報吿期內純利(不計及上述非經常性開支及我們於精鋒醫療的股權投資公允價值收益以及外匯影響)由2020年的人民幣3.35億元增加28.7%至2021年的人民幣4.30億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.